Concepedia

Author

Ann Mohrbacher

University of Southern CaliforniaORCID

Also Known As

A. F. Mohrbacher, A. Mohrbacher, A.F. Mohrbacher, Ann F. Mohrbacher, Ann Mohrbacher, Auclair, D., Levy, Joan, Mohrbacher, Ann F.

94

Publications

1.9K

Citations

16

H-Index

26

Concepts

All Affiliations

University of Southern CaliforniaDana-Farber Cancer InstituteNorthwestern UniversityThe Barbara Ann Karmanos Cancer InstituteAzienda Ospedaliero-Universitaria di Modena
AM

About

Ann Mohrbacher is an author at University of Southern California specializing in hematology, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

518

2

Immunology

4

4

390

3

Health Sciences

3

3

317

4

Cell Biology

2

2

89

5

Marrow Transplantation

1

1

12

Ann Mohrbacher

×

19

Publications

1.7K

Citations

15

H-Index

YearCitations

A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma

Jeffrey A. Zonder, Ann Mohrbacher, Seema Singhal,

Blood

2011

339

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Thomas A. Davis, Christine A. White, A.J. Grillo-López,

Journal of Clinical Oncology

1999

289

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

Andrzej Jakubowiak, Massimo Offidani, Brigitte Pegourié,

Blood

2016

231

Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma

Andrzej Jakubowiak, Don M. Benson, William Bensinger,

Journal of Clinical Oncology

2012

202

TRALI due to granulocyte‐agglutinating human neutrophil antigen‐3a (5b) alloantibodies in donor plasma: a report of 2 fatalities

Anne Davoren, Brian R. Curtis, Ira A. Shulman,

Transfusion

2003

161

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Donna Reece, Dan M. Sullivan, Sagar Lonial,

Cancer Chemotherapy and Pharmacology

2010

106

Quantitative measure of c-abl andp15 methylation in chronic myelogenous leukemia: biological implications

TuDung T. Nguyen, Ann Mohrbacher, Yvonne Tsai,

Blood

2000

88

Role of interleukin 6 in the growth of myelomaderived cell lines

Bruce Barut, Leonard I. Zon, Maria K. Cochran,

Leukemia Research

1992

73

Indatuximab Ravtansine (BT062) in Combination with Low-Dose Dexamethasone and Lenalidomide or Pomalidomide: Clinical Activity in Patients with Relapsed / Refractory Multiple Myeloma

Kevin R. Kelly, David S. Siegel, Asher Chanan‐Khan,

Blood

2016

54

Reversal of advanced renal dysfunction on bortezomib treatment in multiple myeloma patients

Ann Mohrbacher, A. M. Levine

Journal of Clinical Oncology

2005

22

Page 1